Schizophrenia Research

Article	Citations
Re-inventing the schizophrenia syndrome: The elusive “theory of everything”	78
Searching for the “final proof” of schizophrenia	69
A 20-year review comparing the use of ‘schizophrenia’ and ‘psychosis’ in UK newspapers from 2000 to 2019: Implications for stigma reduction	67
Trends in socioeconomic inequalities in incidence of severe mental illness – A population-based linkage study using primary and secondary care routinely collected data between 2000 and 2017	65
Exploring associations between trait symptoms and speech patterns in schizophrenia spectrum disorders: A mediation analysis	60
Reply to Dyadic interaction in schizophrenia – A promising new avenue of investigation?	57
Everyday function in schizophrenia: The impact of aerobic endurance and skeletal muscle strength	56
Meta-analysis of a family history of diabetes in schizophrenia	51
Going the extra mile? The influence of Amisulpride on effort-based decisions	51
Scrutinizing the increased mortality risk associated with the use of typical oral antipsychotics	48
Identification of ultra-rare missense mutations associated with familial schizophrenia by whole-exome sequencing	47
Comorbid psychosis in temporal lobe epilepsy is associated with auditory emotion recognition impairments	46
A profile of high scores on the Peters delusion inventory and low engagement in pandemic-related health behaviors in a non-clinical sample	44
Elevated triglycerides and low triiodothyronine: Key risk factors for coronary artery calcification in patients with schizophrenia	44
Substance use and self-poisoning in schizophrenia: 11-year findings from a national clinical survey of suicide in mental health patients in the UK	43
Measurement invariance of the Revised-Green Paranoid Thought Scale across Black and White Americans	43
Effect of add-on tDCS therapy for auditory hallucinations on frequency and duration deviant mismatch negativity in schizophrenia	41
Electroconvulsive therapy in a patient with positive anti-NMDA receptor antibodies presenting with isolated psychiatric symptoms: A case report	38
Early cognitive development and psychopathology in children at familial high risk for schizophrenia	37
Shortening telomere is associated with psychotic dimensions in the general population	37
App for independence: A feasibility randomized controlled trial of a digital health tool for schizophrenia spectrum disorders	36
Increased likelihood of distressing and functionally impairing psychotic-like experiences among children with co-occurring internalising and externalising problems	36
Frequency of clinical appointments in subjects with emergent suicidal ideation	36
Ethno-racial variation in psychotic experiences in the United States: Findings from the National Latino and Asian American Survey and the National Survey of American Life	35
Creatine kinase levels among asymptomatic patients with severe mental illnesses: A complex baseline for an important clinical biomarker	35

The impact of daily social support on the associations between daily negative events and daily suspiciousness across different clinical stages of psychosis	35
Deconstruction of a screening questionnaire for prodromal psychosis to reduce false positive responses	35
Creating a collaborative culture of learning within a network of community mental health early psychosis programs in Texas	33
Changes in degree centrality and its associated genes: A longitudinal study of patients with schizophrenia undergoing pharmacological treatment	32
Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma	32
How far to go in deconstructing negative symptoms? Behavioural and neural level evidence for the amotivation domain	32
Effect of anticholinergic burden on brain activity during Working Memory and real-world functioning in patients with schizophrenia	31
Associations between acceptance of the implausible bias, theory of mind and delusions in first-episode psychosis patients; A longitudinal study	31
Exploring phenotypic overlap across schizotypy and autism spectrum conditions in American and Chinese young adults	30
Alterations in fatty acid metabolism in patients with schizophrenia in a multi-omics perspective	29
Exploring peripheral biomarkers of response to simvastatin supplementation in schizophrenia	28
Interpersonal distance in schizophrenia: A systematic review	27
Deconstructing emotion regulation in schizophrenia: The nature and consequences of abnormalities in monitoring dynamics	27
Association between initial clozapine titration and pneumonia risk among patients with schizophrenia in a Korean tertiary hospital	27
Effects of country of origin and wave of immigration on prevalence of schizophrenia among first and second-generation immigrants: A 30-year retrospective study	27
Long-term safety and effectiveness of open-label lurasidone in antipsychotic-Naïve versus previously treated adolescents with Schizophrenia: A post-hoc analysis	26
Testing two theories of social support benefits and implications for individuals with psychotic-like experiences	26
Comments on the manuscript: Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self-experience	25
Selection bias in clinical studies of first-episode psychosis: A follow-up study	25
Automated linguistic analysis in speech samples of Turkish-speaking patients with schizophrenia-spectrum disorders	24
Human endogenous retroviruses type W (HERV-) activation and schizophrenia: A meta-analysis	24
Exploring the conceptualisation, measurement, clinical utility and treatment of formal thought disorder in psychosis: A Delphi study	24
Denial of anosognosia in schizophrenia	23
Can clozapine be used for treatment-refractory behavioral and psychological symptoms in dementia patients?	23
Overactive, aggressive, disruptive and agitated behavior associated with the use of psychotropic medications in schizophrenia	23
The schizophrenia syndrome, circa 2024: What we know and how that informs its nature	23
Gut microbial changes of patients with psychotic and affective disorders: A systematic review	23
Psychotic experiences predict subsequent loneliness among adolescents: A population-based birth cohort study	22
Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment	22
Investigation on the association between perceived family expressed emotion, self-stigma, and subjective quality of life in people with early psychosis in Hong Kong: A cross-sectional approach	22
Neurodegenerative model of schizophrenia: Growing evidence to support a revisit	22
The validity of atypical psychosis diagnostic criteria to detect anti-NMDA receptor encephalitis with psychiatric symptoms	22
Deciphering language disturbances in schizophrenia: A study using fine-tuned language models	21
Promoting implementation of deployment-ready psychosocial interventions	21
COVID-19 dimensions and psychotic experiences among US college students: Findings from the Healthy Mind Study 2020	21
Characterization and modulation of voltage-gated potassium channels in human lymphocytes in schizophrenia	21
Decision tree classification of cognitive functions with D2 receptor occupancy and illness severity in late-life schizophrenia	21
Volumetric alteration of olfactory bulb and immune-related molecular changes in olfactory epithelium in first episode psychosis patients	21
Switching a combination of first- and second-generation antipsychotic polypharmacy to antipsychotic monotherapy in long-term inpatients with schizophrenia and related disorders. The SwAP trial II: Res	21
Loneliness, social isolation and suicide risk in people with psychotic disorders	21
Climatic exposures in childhood and the risk of schizophrenia from childhood to early adulthood	20
Harnessing stem cell-based approaches for clinically meaningful discoveries in schizophrenia	20
Mediating role of metacognitive beliefs and cognitive-attentional syndrome in the relationship between persecutory and coronavirus conspiracy beliefs in a community sample	20
Arousal responses to personal space intrusions in psychotic illness: A virtual reality study	20
Primary and secondary negative symptoms severity and the use of psychiatric care resources in schizophrenia spectrum disorders: A 3-year follow-up longitudinal retrospective study	20
Augmentation of learning in schizophrenia by d-serine and auditory remediation is related to auditory and frontally-generated biomarkers: A randomized, double-blind, placebo-controlled study	20
Immunosenescence-related T cell phenotypes and white matter in schizophrenia patients with tardive dyskinesia	20
Short-term antipsychotic treatment response in early-onset, typical-onset, and late-onset first episode schizophrenia	20
Personal recovery suits us all: A study in patients with non-affective psychosis, unaffected siblings and healthy controls	19
Mismatch negativity in schizophrenia spectrum and bipolar disorders: Group and sex differences and associations with symptom severity	19

Computational psychiatry and the psychopathology of psychosis: Promising leads and blind alleys	19
Brief video intervention to reduce stigma of family and friends of people living with serious mental illness	19
The impact of early intervention for first episode psychosis on cognitive functioning	19
Personal recovery in first-episode psychosis: Beyond clinical and functional recovery	19
I am a person, not an illness	19
Sedentary behaviour in young people presenting with a first episode of psychosis before and during the covid-19 pandemic restrictions	18
A call to action: Increased mortality from COVID-19 among individuals with schizophrenia calls for coordinated vaccination efforts	18
Issue Highlights	18
Clozapine discontinuation and rechallenge in suspected myocarditis: An analysis of seven cases	18
Differential gene expression study in whole blood identifies candidate genes for psychosis in African American individuals	18
Spontaneous neural activity underlying neutral and happy speech recognition in noise and its association with psychiatric symptoms in patients with schizophrenia	18
Overview on cognitive impairment in psychotic disorders: From impaired microcircuits to dysconnectivity	18
Relations of temporoparietal connectivity with neighborhood social fragmentation in youth at clinical high-risk for psychosis	18
Corrigendum to “Jang YJ, et al. Characterizing the relationship between personality dimensions and psychosis-specific clinical characteristics” [Schizophr Res. 276 (2025) 88–96 10.1016/j.schres.2025.0	18
Alteration in left frontoparietal connectivity correlates with impaired cognitive reappraisal in early psychosis	18
Effects of PDE10A inhibitor MK-8189 in people with an acute episode of schizophrenia: A randomized proof-of-concept clinical trial	17
A systematic review of dramatherapy interventions used to support adults with psychosis	17
Probing the molecular and cellular pathological mechanisms of schizophrenia using human induced pluripotent stem cell models	17
Improving dependability in science: A critique on the psychometric qualities of the HiTOP psychosis superspectrum	17
Racial microaggressions and major discriminatory events explain ethnoracial differences in psychotic experiences	17
INTERACT: a randomized phase 2 study of the DAAO inhibitor luvadaxistat in adults with schizophrenia	17
Abnormalities in motor adaptation to different types of perturbations in schizophreniaperturbations in schizophrenia	17
Mitochondrial dysfunction in psychiatric disorders	17
Exploring the relationship between the gut microbiota and cognitive function in schizophrenia patients with distinct weights	17
Current progress in understanding schizophrenia using genomics and pluripotent stem cells: A meta-analytical overview	17
Integrating rare variant genetics and brain transcriptome data implicates novel schizophrenia putative risk genes	17
Acceptance and Commitment Therapy-based Lifestyle Counselling Program for people with early psychosis on physical activity: A pilot randomized controlled trial	17
Schizophrenia among young people first admitted to psychiatric inpatient care during early and middle adolescence	17
Factors and their weight in reducing life expectancy in schizophrenia	17
Social brain network correlates with real-life social network in individuals with schizophrenia and social anhedonia	16
Pupillary light reflex markers of suicide risk in a trans-diagnostic sample	16
Avolition predicts variability in optimal risk-taking in early psychosis	16
Agoraphobic avoidance in patients with psychosis: Severity and response to automated VR therapy in a secondary analysis of a randomised controlled clinical trial	16
Issue highlights	16
Disparities in technology literacy and access negatively impact cognitive remediation scalability	16
Language network self-inhibition and semantic similarity in first-episode schizophrenia: A computational-linguistic and effective connectivity approach	16
Patient-reported outcome measures in early psychosis: A cross-cultural, longitudinal examination of the self-reported health and self-reported mental health measures in Chennai, India and Montreal, Ca	16
Insight and suicidality in first-episode psychosis: The mediating role of depression	16
Multi-omics analysis reveals the impact of gut microbiota on antipsychotic-induced weight gain in schizophrenia	16
Associations between fearlessness about death and suicidal ideation in individuals with psychosis	16
Letter on: “Lower risk of SARS-CoV2 infection in individuals with severe mental disorders on antipsychotic treatment: A retrospective epidemiological study in a representative Spanish population”	15
Can antipsychotic use protect from COVID-19?	15
The association between area-level factors and mortality in severe mental illnesses: A systematic review	15
Issue highlights	15
Aberrant salience predicts fluctuations of paranoia two weeks in advance during a 1-year experience sampling method study in people with psychosis	15
Reprint of Altered corollary discharge in the auditory cortex could reflect louder inner voice experience in patients with verbal hallucinations, a pilot fMRI study	15
Redefining schizophrenia through genetics: A commentary on 50 years searching for biological causes	15
Proximate markers of cognitive dysfunction in schizophrenia	15
Sulfur-containing amino acids and risk of schizophrenia	15
Longitudinal and cross-sectional validation of the WERCAP screen for assessing psychosis risk and conversion	15
Editorial Board	15
Exploring the relationship between baseline health-related quality of life (AQoL-4D utility values) and mortality during long-term follow-up for people living with a psychotic disorder	15
Interoceptive functioning in schizophrenia and schizotypy	15
Neurocognitive function and delusion severity in schizophrenia spectrum disorders	14
Arthur Schopenhauer: An underappreciated philosopher in psychiatry and his applied epistemology of body and self- experience	14
Identifying strategies to improve PANSS based dimensional models in schizophrenia: Accounting for multilevel structure, Bayesian model and clinical staging	14
Alexithymia in chronic schizophrenia and its mediating effect between cognitive deficits and negative symptoms	14
The timing and severity of clozapine-associated neutropenia in the US: Is the risk overstated?	14
Olfactory dysfunction in schizophrenia and other psychotic disorders: A comprehensive and updated meta-analysis	14
Complex chronic conditions among children born to women with schizophrenia	14
Do you like cliff-hangers? Objective versus subjective need for closure in the schizophrenia spectrum	14
Perineuronal net density in schizophrenia: A systematic review of postmortem brain studies	14
The phenomenological nature of schizophrenia and disorder of selfhood	14
MicroRNA-regulated suppression of some overexpressed genes in schizophrenia and their evolutionary significance	14
Modeling common and rare genetic risk factors of neuropsychiatric disorders in human induced pluripotent stem cells	14
Accessibility of psychiatric vocabulary: An international study about schizophrenia essential features	14
The diagnosis and treatment of catatonia via telemedicine: A case report and proposed diagnostic criteria	14
Systematic review and meta-analysis of family-based interventions for early psychosis: Carer and patient outcomes	14
Subjective self-experiences at the mirror in patients with schizophrenia	13
Relationship between psychopathological symptoms and dimensions in inpatients with schizophrenia: A network analysis	13
Defeatist beliefs about performance are important treatment targets for negative symptoms in the early course of schizophrenia	13
Identifying clinical predictors for considering brain FDG-PET imaging in patients with catatonia: A case-control study	13
Functional network interactions in patients with schizophrenia with persistent auditory verbal hallucinations: A multimodal MRI fusion approach using three-way pICA	13
Single trajectory treatment response for predominant negative symptoms: Post-hoc analysis of a clinical trial with cariprazine and risperidone	13
Editorial Board	13
A useful construct to improve the lives of people with schizophrenia	13
Changes in social functioning over the course of psychotic disorders–A meta-analysis	13
Efficacy of KarXT on negative symptoms in acute schizophrenia: A post hoc analysis of pooled data from 3 trials	13
Editorial Board	13
A role for endothelial NMDA receptors in the pathophysiology of schizophrenia	13

The contributions of risk-taking and impulsivity to jumping to conclusions in the psychosis spectrum	13
Elemental dysregulation in psychotic spectrum disorders: A review and research synthesis	13
Initial evidence of vowel space reduction in a subset of individuals with schizophrenia	13
Negative mood states as a correlate of cognitive performance and self-assessment of cognitive performance in bipolar disorder versus schizophrenia	13
Levetiracetam effects on hippocampal blood flow and symptoms in medication-free individuals with nonaffective first episode psychosis (letter)	13
Renaming schizophrenia in Argentina: Could a change of name resolve the stigma? Results from a national survey	13
Catatonia is associated with higher rates of negative affect amongst patients with schizophrenia and schizoaffective disorder	13
Issue highlights	13
Outcomes for first-episode psychosis after entry via an at-risk mental state clinic compared to direct entry to a first episode of psychosis service: A systematic review and meta-analysis	13
Psychotic-like experiences in a nationally representative study of general population adolescents	13
SARPEP, a rapid-learning healthcare system of early intervention services for psychosis in Quebec, Canada: Feasibility, acceptability and early impacts	13
The role of defeatist performance beliefs on cognitive effort-cost decision-making in schizophrenia	13
Ex vivo 1H-MRS brain metabolic profiling in a two-hit model of neurodevelopmental disorders: Prenatal immune activation and peripubertal stress	13
Effect of schizophrenia risk gene polymorphisms on cognitive and neural plasticity	13
Reshaping the diagnostic borders: Historical analysis of the diagnostic changes following the introduction of the schizophrenia concept	13
Pathways to care: Source of referral at first-episode psychosis, a cross-country comparison between Bologna and South London	13
Does affect mediate the relationship between interpersonal trauma and psychosis? A systematic review and meta-analysis	13
Increased prevalence of the Heschl's gyrus duplication pattern common to various first-episode psychoses	13
Gender-specific elevation of plasma anthranilic acid in schizophrenia: Protection against glutamatergic hypofunction?	13
Catatonia is an outpatient reality. What do we do now?	12
An integrative study of the microbiome gut-brain-axis and hippocampal inflammation in psychosis: Persistent effects from mode of birth	12
Antineuronal antibodies in cerebrospinal fluid and serum of 104 patients with psychotic disorders compared to 104 individually matched healthy controls	12
The introduction of clozapine at the Nathan Kline Institute in New York and its long-term consequences	12
Early improvement as a predictor of response to blonanserin transdermal patch in patients with schizophrenia	12
Ultrastructural evidence for glutamatergic dysregulation in schizophrenia	12
Highlights	12
Social anhedonia in the daily lives of people with schizophrenia: Examination of anticipated and consummatory pleasure	12
Relationships between neuropsychological performance, insight, medication adherence, and social metacognition in schizophrenia	12
Microstructural white matter biomarkers of symptom severity and therapy outcome in catatonia: Rationale, study design and preliminary clinical data of the whiteCAT study	12
Clozapine research standards in former USSR states: A systematic review of quality issues with recommendations for future harmonization with modern research standards	12
Insulin resistance and lipid levels in the middle-aged offspring of parents with severe mental illness	12
Decrease in gamma-band auditory steady-state response in patients with treatment-resistant schizophrenia	12
Validity and reliability of the Vigour Assessment Scale in avolitional schizophrenia outpatients	12
Schizophrenia, the very idea: On self-disorder, hyperreflexivity, and the diagnostic concept	12
Sleep patterns in treated and untreated patients of schizophrenia	12
Automatic identification of schizophrenia employing EEG records analyzed with deep learning algorithms	12
Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition	12
The impact of cigarette smoking on life expectancy in schizophrenia, schizoaffective disorder and bipolar affective disorder: An electronic case register cohort study	12
COVID-19 infection, fluctuations in the clozapine/norclozapine levels and metabolic ratio and clozapine toxicity: An illustrative case-report	12
Why and how might yoga differ from other mind-body approaches in schizophrenia?	11
Predicting the onset of psychotic experiences in daily life with the use of ambulatory sensor data – A proof-of-concept study	11
The neuromuscular basis of functional impairment in schizophrenia: A scoping review	11
‘Thinking about Them is only making me feel worse’. The mediating role of metacognitive factors in the relationship between paranoia-like beliefs and psychopathology symptoms in a community sample	11
Reframing schizophrenia: Altering our perceptions?	11
Efficacy and tolerability of antipsychotic polypharmacy for schizophrenia spectrum disorders. A systematic review and meta-analysis of individual patient data	11
Cell line specific alterations in genes associated with dopamine metabolism and signaling in midbrain dopaminergic neurons derived from 22q11.2 deletion carriers with elevated dopamine synthesis capac	11
Promoting safer and wider worldwide use of clozapine	11
Feasibility and Acceptability of a Physical Activity Group Program Using telerehabilitation during the COVID-19 Pandemic in Multiple early Intervention for Psychosis Services	11
Clozapine toxicity and coronavirus disease 2019: A case report	11
Editorial Board	11
Editorial Board	11
Cognitive-Behavioral Social Skills Training for patients with late-life schizophrenia and the moderating effect of executive dysfunction	11
The use of adaptive emotion regulation strategies in people with attenuated psychotic symptoms – Results from a two-week diary study	11
Neuroanatomical subtypes of schizophrenia and relationship with illness duration and deficit status	11
The unfulfilled promise of equitable first episode care for Black-Americans: A way forward	11
Can peripheral brain-derived neurotrophic factor (BDNF) be a potential biomarker of suicide risk in schizophrenia?	11
Grey matter volume reduction in the frontotemporal cortex associated with persistent verbal auditory hallucinations in Chinese patients with chronic schizophrenia: Insights from a 3 T magnetic resonan	11
Editorial Board	11
Toxoplasma gondii, Herpesviridae and long-term risk of transition to first-episode psychosis in an ultra high-risk sample	11
Editorial Board	11
Investigating bilirubin concentrations in schizophrenia: A systematic review and meta-analysis	11
Self and time in individuals with schizophrenia: A motor component?	11
Everything is connected: Inference and attractors in delusions	11
Clozapine in treatment-resistant schizophrenia: Who designed that famous US clinical trial?	11
A psychological intervention for engaging dialogically with auditory hallucinations (Talking With Voices): A single-site, randomised controlled feasibility trial	11
Factor structure of social cognition in schizophrenia: Investigation of four core domains	11
Reply to dynamic network analysis of schizophrenia spectrum traits, affective symptoms, and social functioning—Opportunities and challenges	11
Retinal electrophysiological alterations are associated with cognition in early course psychosis	11
Abnormalities in emotion regulation are associated with negative, but not positive or disorganized schizotypy: An experience sampling study	11
Long-term quality of life and social disconnection 20 years after a first episode psychosis, results from the 20-year follow-up of the OPUS trial	11
Attention-deficit/hyperactivity disorder in youth with psychosis spectrum symptoms	11
Treatment resistance NMDA receptor pathway polygenic score is associated with brain glutamate in schizophrenia	11
Issue highlights	11
Randomized, double-blind, sham-controlled trial to evaluate the efficacy and tolerability of electroconvulsive therapy in patients with clozapine-resistant schizophrenia	10
Epidemiology of psychotic-like experiences by subtypes and their relationship with emotional regulation and affective lability among Chinese college students	10
Obsessive-compulsive symptoms and personal recovery in patients with schizophrenia spectrum disorders: A cross-sectional study	10
Psychopathology and psychosocial functioning among young people with first-episode psychosis and/or first-presentation borderline personality disorder	10
Aberrant salience signaling in auditory processing in schizophrenia: Evidence for abnormalities in both sensory processing and emotional reactivity	10
Functional and structural abnormalities of thalamus in individuals at early stage of schizophrenia	10
Negative symptoms in schizophrenia: Newly emerging measurements, pathways, and treatments	10
Antipsychotic treatment strategies for acute phase and treatment resistance in schizophrenia: A systematic review of the guidelines and algorithms	10
The cellular mechanism of antipsychotic-induced myocarditis: A systematic review	10
Issue Highlights	10
Clinical phenotypes of five patients with psychotic disorders carrying rare schizophrenia-associated loss-of-function variants	10
Assessment of patient life engagement in schizophrenia using items from the Positive and Negative Syndrome Scale	10
Higher central set point of thyroid homeostasis in drug-naïve patients affected by first episode schizophrenia	10
Anomalous self-experiences (ASE) in relation to clinical high risk for psychosis (CHR P), childhood trauma and general psychopathology among adolescent and young adult help seekers	10
Prenatal infection and schizophrenia: A decade of further progress	10
Clozapine ultrarapid metabolism during weak induction probably exists but requires careful diagnosis. A literature review, five new cases and a proposed definition	10
Sub-clinical systemic inflammation as a determinant of admission duration in psychosis	10
Complement component 4A protein levels are negatively related to frontal volumes in patients with schizophrenia spectrum disorders	10
Hasty decision making and belief inflexibility in the more delusion prone? A modified disambiguating-scenarios paradigm assessing cognitive biases implicated in delusions	10
Impact of lifetime stressor exposure on neuroenergetics in schizophrenia spectrum disorders	10
Toxoplasmosis infection and schizophrenia: Elevated IgM reactivity index as a predictor of symptom worsening in chronic schizophrenia	10
Predictors of relapse and engagement in care one year after ending services in an urban safety net coordinated specialty care program for first episode psychosis	9